English
Segment disclosures
Company overviewINGREDION INCORPORATED
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Intersegment Elimination · Food And Industrial Ingredients LATAM Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsLATAMSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -11000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -21000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -10000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -51000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -12000000 | USD | 20251107 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -39000000 | USD | 20251107 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -14000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -27000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -13000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -47000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -13000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -33000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -10000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -20000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -10000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -35000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | -7000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | -26000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | -9000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | -19000000 | USD | 20240808 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -59000000 | USD | 20250220 | Open filing evidence |
Intersegment Elimination · Food And Industrial Ingredients U.S.Canada Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -48000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -75000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -27000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -108000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -25000000 | USD | 20251107 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -85000000 | USD | 20251107 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -27000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -60000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -33000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -89000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -19000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -70000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -25000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -51000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -26000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -94000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | -22000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | -72000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | -23000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | -50000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | -27000000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -101000000 | USD | 20250220 | Open filing evidence |
Intersegment Elimination · Texture And Healthful Solutions Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=ingr:TextureAndHealthfulSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -35000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -44000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -9000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -32000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -7000000 | USD | 20251107 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -25000000 | USD | 20251107 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -9000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -18000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -9000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -51000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -11000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -42000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -16000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -31000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -15000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -106000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | -26000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | -84000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | -25000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | -58000000 | USD | 20240808 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -185000000 | USD | 20250220 | Open filing evidence |
Operating Segments · Food And Industrial Ingredients LATAM Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsLATAMSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 622000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1211000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 589000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2392000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 597000000 | USD | 20251107 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1793000000 | USD | 20251107 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 610000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1196000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 586000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2497000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 633000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1899000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 640000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1266000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 626000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2668000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 665000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2017000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 675000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1352000000 | USD | 20240808 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2628000000 | USD | 20250220 | Open filing evidence |
Operating Segments · Food And Industrial Ingredients U.S.Canada Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 536000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1038000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 502000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2121000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 532000000 | USD | 20251107 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1635000000 | USD | 20251107 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 550000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1103000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 553000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2244000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 567000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1714000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 580000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1147000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 567000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2429000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 621000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1883000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 627000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1262000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 635000000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2303000000 | USD | 20250220 | Open filing evidence |
Operating Segments · Texture And Healthful Solutions Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:TextureAndHealthfulSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 662000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1288000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 626000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2429000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 612000000 | USD | 20251107 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1831000000 | USD | 20251107 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 608000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1219000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 611000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2417000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 611000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1827000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 604000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1216000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 612000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2566000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 625000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1966000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 643000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1341000000 | USD | 20240808 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2527000000 | USD | 20250220 | Open filing evidence |
Operating Segments · Asia Pacific Segment
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:AsiaPacificSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 201000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 395000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 194000000 | USD | 20180504 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 187000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 366000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 179000000 | USD | 20180504 | Open filing evidence |
Operating Segments · EMEA Segment
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:EMEASegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 147000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 299000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 152000000 | USD | 20180504 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 137000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 275000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 138000000 | USD | 20180504 | Open filing evidence |
Operating Segments · North America Segment
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 916000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 1790000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 874000000 | USD | 20180504 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 905000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 1786000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 881000000 | USD | 20180504 | Open filing evidence |
Operating Segments · South America Segment
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ingr:SouthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-04-01 – 2018-06-30 | 232000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 481000000 | USD | 20180803 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 249000000 | USD | 20180504 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 228000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 483000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 255000000 | USD | 20180504 | Open filing evidence |
Asia Pacific Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:AsiaPacificSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 1089000000 | USD | 20240221 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 272000000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 816000000 | USD | 20231107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 267000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 544000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 277000000 | USD | 20230516 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1107000000 | USD | 20240221 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 278000000 | USD | 20231107 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 825000000 | USD | 20231107 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 275000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 547000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 272000000 | USD | 20230516 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 997000000 | USD | 20240221 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 245000000 | USD | 20221107 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 728000000 | USD | 20221107 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 248000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 483000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 235000000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 813000000 | USD | 20230221 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 207000000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 583000000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 187000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 376000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 189000000 | USD | 20210507 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 823000000 | USD | 20220222 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 205000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 611000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 203000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 406000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 203000000 Restated | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 837000000 Restated | USD | 20210224 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 197000000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 592000000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 201000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 395000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 194000000 | USD | 20190503 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 772000000 Restated | USD | 20200219 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 189000000 | USD | 20181102 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 555000000 | USD | 20181102 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 187000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 366000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 179000000 | USD | 20180504 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 709000000 | USD | 20190225 | Open filing evidence |
EMEA Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:EMEASegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 821000000 | USD | 20240221 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 192000000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 630000000 | USD | 20231107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 203000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 438000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 235000000 | USD | 20230516 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 781000000 | USD | 20240221 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 190000000 | USD | 20231107 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 579000000 | USD | 20231107 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 195000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 389000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 194000000 | USD | 20230516 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 703000000 | USD | 20240221 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 175000000 | USD | 20221107 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 514000000 | USD | 20221107 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 178000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 339000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 161000000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 593000000 | USD | 20230221 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 143000000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 429000000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 132000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 286000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 154000000 | USD | 20210507 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 592000000 | USD | 20220222 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 140000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 438000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 144000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 298000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 154000000 Restated | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 607000000 Restated | USD | 20210224 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 136000000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 435000000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 147000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 299000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 152000000 | USD | 20190503 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 577000000 Restated | USD | 20200219 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 136000000 | USD | 20181102 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 411000000 | USD | 20181102 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 137000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 275000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 138000000 | USD | 20180504 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 538000000 | USD | 20190225 | Open filing evidence |
Food And Industrial Ingredients LATAM Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsLATAMSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 624000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1814000000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 611000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1190000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 579000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2341000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 585000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1754000000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 596000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1169000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 573000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2450000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 620000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1866000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 630000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1246000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 616000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2633000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 658000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1991000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 666000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1333000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 667000000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2569000000 | USD | 20250220 | Open filing evidence |
Food And Industrial Ingredients LATAM Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsLATAMSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | -17000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | -38000000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -12000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -39000000 | USD | 20261106 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -10000000 | USD | 20240509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | -10000000 | USD | 20240509 | Open filing evidence |
Food And Industrial Ingredients LATAM Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsLATAMSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 641000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1852000000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 597000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1793000000 | USD | 20261106 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 626000000 | USD | 20240509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 677000000 | USD | 20240509 | Open filing evidence |
Food And Industrial Ingredients U.S.Canada Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 504000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1467000000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 488000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 963000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 475000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2013000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 507000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1550000000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 523000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1043000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 520000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2155000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 548000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1644000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 555000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1096000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 541000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2335000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 599000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1811000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 604000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1212000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 608000000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2202000000 | USD | 20250220 | Open filing evidence |
Food And Industrial Ingredients U.S.Canada Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | -37000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | -112000000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -25000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -85000000 | USD | 20261106 | Open filing evidence |
Food And Industrial Ingredients U.S.Canada Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:FoodAndIndustrialIngredientsU.S.CanadaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 541000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1579000000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 532000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1635000000 | USD | 20261106 | Open filing evidence |
North America Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 5188000000 | USD | 20240221 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1300000000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3998000000 | USD | 20231107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1342000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2698000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1356000000 | USD | 20230516 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 4934000000 | USD | 20240221 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1262000000 | USD | 20231107 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3720000000 | USD | 20231107 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1284000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 2458000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1174000000 | USD | 20230516 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 4137000000 | USD | 20240221 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1083000000 | USD | 20221107 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 3096000000 | USD | 20221107 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1068000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 2013000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 945000000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 3662000000 | USD | 20230221 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 928000000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 2739000000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 848000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1811000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 963000000 | USD | 20210507 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 3834000000 | USD | 20220222 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 984000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2912000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 977000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1928000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 951000000 Restated | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 3857000000 Restated | USD | 20210224 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 889000000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 2679000000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 916000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 1790000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 874000000 | USD | 20190503 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 3843000000 Restated | USD | 20200219 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 903000000 | USD | 20181102 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 2689000000 | USD | 20181102 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 905000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 1786000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 881000000 | USD | 20180504 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 3447000000 | USD | 20190225 | Open filing evidence |
South America Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:SouthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 1062000000 | USD | 20240221 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 269000000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 795000000 | USD | 20231107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 257000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 526000000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 269000000 | USD | 20230516 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1124000000 | USD | 20240221 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 293000000 | USD | 20231107 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 835000000 | USD | 20231107 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 290000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 542000000 | USD | 20230808 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 252000000 | USD | 20230516 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1057000000 | USD | 20240221 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 260000000 | USD | 20221107 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 801000000 | USD | 20221107 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 268000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 541000000 | USD | 20220809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 273000000 | USD | 20220506 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 919000000 | USD | 20230221 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 224000000 | USD | 20211105 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 643000000 | USD | 20211105 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 182000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 419000000 | USD | 20210806 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 237000000 | USD | 20210507 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 960000000 | USD | 20220222 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 245000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 699000000 Restated | USD | 20201106 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 226000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 454000000 Restated | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 228000000 Restated | USD | 20200506 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 988000000 Restated | USD | 20210224 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 228000000 | USD | 20191106 | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 709000000 | USD | 20191106 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 232000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 481000000 | USD | 20190802 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 249000000 | USD | 20190503 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 1052000000 Restated | USD | 20200219 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 257000000 | USD | 20181102 | Open filing evidence |
| 2017-01-01 – 2017-09-30 | 740000000 | USD | 20181102 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 228000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-06-30 | 483000000 | USD | 20180803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 255000000 | USD | 20180504 | Open filing evidence |
| 2016-01-01 – 2016-12-31 | 1010000000 | USD | 20190225 | Open filing evidence |
Texture And Healthful Solutions Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:TextureAndHealthfulSolutionsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 610000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1854000000 | USD | 20261106 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 627000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1244000000 | USD | 20260807 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 617000000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2397000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 605000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1806000000 | USD | 20261106 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 599000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1201000000 | USD | 20260807 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 602000000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2366000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 600000000 | USD | 20251107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1785000000 | USD | 20251107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 588000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1185000000 | USD | 20250811 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 597000000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2460000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 599000000 | USD | 20241108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1882000000 | USD | 20241108 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 618000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1283000000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 665000000 | USD | 20240509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2342000000 | USD | 20250220 | Open filing evidence |
Texture And Healthful Solutions Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:TextureAndHealthfulSolutionsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | -22000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | -66000000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -7000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -25000000 | USD | 20261106 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -15000000 | USD | 20240509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | -33000000 | USD | 20240509 | Open filing evidence |
Texture And Healthful Solutions Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ingr:TextureAndHealthfulSolutionsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 632000000 | USD | 20261106 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1920000000 | USD | 20261106 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 612000000 | USD | 20261106 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1831000000 | USD | 20261106 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 612000000 | USD | 20240509 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 698000000 | USD | 20240509 | Open filing evidence |